U.S. Markets closed

Why This Gene Therapy Stock Looks Like A Sure Takeover Bet: Analyst

ALLISON GATLIN
Why This Gene Therapy Stock Looks Like A Sure Takeover Bet: Analyst

Gene therapy player Uniqure could head to the auction block, an analyst said Monday as shares of the biotech company popped. He also said Roche's plan to buy Spark Therapeutics could falter.